Humana Inc. (NYSE:HUM) Stock Position Increased by Calamos Advisors LLC

Calamos Advisors LLC boosted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 8.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,948 shares of the insurance provider's stock after buying an additional 6,207 shares during the period. Calamos Advisors LLC owned 0.06% of Humana worth $35,228,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Rakuten Securities Inc. purchased a new stake in shares of Humana during the 4th quarter valued at $25,000. Sunbelt Securities Inc. purchased a new stake in shares of Humana during the 1st quarter valued at $28,000. Gradient Investments LLC increased its position in shares of Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 40 shares during the period. Householder Group Estate & Retirement Specialist LLC acquired a new position in shares of Humana in the 3rd quarter valued at $39,000. Finally, Nvwm LLC increased its position in shares of Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider's stock valued at $42,000 after acquiring an additional 25 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. TheStreet downgraded Humana from a "b" rating to a "c+" rating in a research report on Monday, January 8th. Argus downgraded Humana from a "buy" rating to a "hold" rating in a research report on Wednesday, March 13th. UBS Group reaffirmed a "neutral" rating and set a $370.00 price target (down from $530.00) on shares of Humana in a research report on Friday, January 26th. Raymond James assumed coverage on Humana in a research report on Friday, March 22nd. They set a "market perform" rating on the stock. Finally, Wells Fargo & Company cut their price target on Humana from $413.00 to $350.00 and set an "overweight" rating on the stock in a research report on Monday, April 8th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $465.42.

Humana Price Performance

Humana stock traded up $1.37 during midday trading on Thursday, reaching $324.83. The company had a trading volume of 1,475,257 shares, compared to its average volume of 2,009,200. The company has a market capitalization of $39.19 billion, a P/E ratio of 16.39, a P/E/G ratio of 1.86 and a beta of 0.45. Humana Inc. has a 12-month low of $299.23 and a 12-month high of $541.21. The firm's fifty day simple moving average is $343.55 and its 200-day simple moving average is $425.01. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The business had revenue of $26.46 billion during the quarter, compared to analysts' expectations of $25.47 billion. During the same period last year, the business earned $1.62 earnings per share. The company's revenue for the quarter was up 17.9% compared to the same quarter last year. As a group, equities analysts anticipate that Humana Inc. will post 16.06 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.09%. Humana's dividend payout ratio (DPR) is 17.86%.

Insiders Place Their Bets

In other Humana news, Director Jorge S. Mesquita bought 545 shares of the firm's stock in a transaction on Tuesday, February 20th. The shares were acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company's stock, valued at approximately $946,358.02. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.32% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.